GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Insys Therapeutics Inc. (INSY) [hlAlert]

Rating:
Perform INSY
up 496.66 %

Insys Therapeutics Inc. (INSY) rated Perform with price target $40 by Oppenheimer

Posted on: Wednesday,  Nov 12, 2014  8:25 AM ET by Oppenheimer

Oppenheimer rated Perform Insys Therapeutics Inc. (NASDAQ: INSY) on 11/12/2014. Previously Oppenheimer rated Outperform Insys Therapeutics Inc. (NASDAQ: INSY) on 07/31/2013.,
when the stock price was $5.57. Since then, Insys Therapeutics Inc. has gained 496.67% as of 01/26/2016's recent price of $33.25.
If you would have followed the previous Oppenheimer's recommendation on INSY, you would have gained 496.66% of your investment in 909 days.

Neopharm Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of drugs for the treatment of cancer and other diseases. The Company built its drug development program around two technology platforms: a tumor-targeting toxin platform and NeoLipid liposomal drug delivery system. Neopharm has five drug product candidates in various stages of clinical and pre-clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis (IPF) and asthma.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2014 8:25 AM Buy
None
20.03 20.00
as of 10/17/2014
1 Week up  0.53 %
1 Month up  10.60 %
3 Months up  48.69 %
1 YTD up  44.81 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/14/2013 8:25 AM Buy
None
7.63 9.18
7/31/2013 8:25 AM Buy
None
5.57 7.82

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy